Factors associated with peripheral blood stem cell yield in healthy pediatric donors

Gülsün Karasu1, Vedat Uygun1, Akif Yesilipek1

  • 1Medicalpark Antalya Hospital, Pediatric Stem Cell Transplantation Unit, Antalya, Turkey.

Insights

Predicting stem cell yield in pediatric donors is crucial. Donor weight ratio and circulating CD34+ cell counts on apheresis day help predict peripheral blood stem cell (PBSC) yield in children.

Area of Science:

  • Pediatric Hematology
  • Stem Cell Transplantation
  • Apheresis Procedures

Background:

  • Limited data exists on predictive factors for CD34+ stem cell yield in healthy pediatric donors.
  • Peripheral blood stem cell (PBSC) donation is utilized in children, necessitating understanding of donor-specific variables.

Purpose of the Study:

  • To identify predictive factors for achieving a target CD34+ stem cell dose (>3×10^6/kg recipient body weight) in pediatric PBSC donors.
  • To analyze the relationship between donor age, weight, and CD34+ cell yield.

Main Methods:

  • Retrospective analysis of 140 apheresis procedures in 100 healthy pediatric donors.
  • Donors categorized into four age groups (0-4, 5-9, 10-14, 15-18 years).
  • Multivariate analysis to determine significant predictors of CD34+ cell collection.

Main Results:

  • The median CD34+ cell yield in the first apheresis was 3.9×10^6/kg recipient body weight.
  • No statistically significant difference in CD34+ cell yield was observed among the different age groups.
  • Donor-to-recipient weight ratio and peripheral CD34+ cell count were significant predictors for achieving >3×10^6/kg RBW of CD34+ cells.

Conclusions:

  • Circulating CD34+ cell concentration on apheresis day is a key predictor of stem cell yield in pediatric donors.
  • The donor-to-recipient weight ratio also plays a significant role in predicting successful CD34+ stem cell collection.
  • These factors can aid in optimizing apheresis procedures for pediatric donors.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.5K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.2K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
6.3K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.9K